NDC codes

FDA NDC Directory
Product NDC (as listed)68611-180Labeler and product segments. Claims need a package NDC.
Product NDC at billing width68611-0180Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
68611-180-0168611018001686110180011 POUCH in 1 CARTON (68611-180-01) / 1 APPLICATOR in 1 POUCH / 1 IMPLANT in 1 APPLICATORMarketed from May 17, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Yutiq
Generic name (nonproprietary)
fluocinolone acetonide
Active ingredients
Fluocinolone acetonide — .18 mg/1
Dosage form
Implant
Route
Intravitreal
Labeler
ANI Pharmaceuticals, Inc.NDC labeler code 68611
Product type
Prescription drug
Marketing category
NDA — New Drug ApplicationApplication NDA 210331
Marketing start
Listing expires
Other FDA classes
Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers
Product ID 68611-180_f684c980-0cfe-11f1-b4ac-0800200c9a66SPL ID f684c980-0cfe-11f1-b4ac-0800200c9a66SPL set ID f270cad8-ed82-4969-b785-831a1910bfa6RxCUI 2099361, 2099366UNII 0CD5FD6S2MUPC 0368611180017
Pharmacologic class
Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N468611018001 followed by a unit qualifier and the quantity

Package 68611-0180-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

1. INDICATIONS AND USAGE YUTIQ ® (fluocinolone acetonide intravitreal implant) 0.18 mg is indicated for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye. YUTIQ contains a corticosteroid and is indicated for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 68611-180

What is NDC 68611-180?
68611-180 is the product NDC for Yutiq (fluocinolone acetonide), Fluocinolone acetonide .18 mg/1 implant, listed with the FDA by ANI Pharmaceuticals, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Yutiq (Fluocinolone acetonide).
What is the active ingredient?
Fluocinolone acetonide.
Who is the labeler?
ANI Pharmaceuticals, Inc., NDC labeler code 68611. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Yutiq?
None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Free account

Log in to keep searching

You’ve used your 3 free searches. Med-Code is free: log in or create a free profile to keep looking up NDCs, J-codes and drugs.

Create a free profileLog in